Revolution Medicines, Inc. (RVMD) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Revolution Medicines, Inc. (RVMD) Bundle
Discover the true potential of Revolution Medicines, Inc. (RVMD) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how changes affect the valuation of Revolution Medicines, Inc. (RVMD) – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.0 | 43.0 | 29.4 | 35.4 | 11.6 | 8.9 | 6.8 | 5.3 | 4.0 | 3.1 |
| Revenue Growth, % | 0 | -14.1 | -31.62 | 20.38 | -67.27 | -23.15 | -23.15 | -23.15 | -23.15 | -23.15 |
| EBITDA | -48.6 | -101.9 | -179.7 | -239.5 | -430.6 | -8.8 | -6.8 | -5.2 | -4.0 | -3.1 |
| EBITDA, % | -97.1 | -237.1 | -611.59 | -676.85 | -3718.32 | -99.42 | -99.42 | -99.42 | -99.42 | -99.42 |
| Depreciation | 3.3 | 6.5 | 7.3 | 9.7 | 9.3 | 2.8 | 2.1 | 1.6 | 1.2 | 1.0 |
| Depreciation, % | 6.68 | 15.23 | 24.95 | 27.29 | 80.39 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 |
| EBIT | -51.9 | -108.5 | -187.1 | -249.1 | -439.9 | -8.9 | -6.8 | -5.3 | -4.0 | -3.1 |
| EBIT, % | -103.78 | -252.33 | -636.54 | -704.14 | -3798.71 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 122.8 | 440.7 | 577.1 | 644.9 | 1,853.0 | 8.9 | 6.8 | 5.3 | 4.0 | 3.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 8.7 | 6.4 | 5.9 | 4.7 | 1.3 | 1.4 | 1.0 | .8 | .6 | .5 |
| Account Receivables, % | 17.46 | 14.87 | 20.17 | 13.21 | 10.83 | 15.31 | 15.31 | 15.31 | 15.31 | 15.31 |
| Inventories | .0 | .0 | -12.7 | .0 | .0 | -.8 | -.6 | -.5 | -.3 | -.3 |
| Inventories, % | 0.000001998361 | 0 | -43.28 | 0.000002826456 | 0 | -8.66 | -8.66 | -8.66 | -8.66 | -8.66 |
| Accounts Payable | 11.4 | 12.6 | 14.1 | 21.3 | 61.8 | 4.6 | 3.6 | 2.7 | 2.1 | 1.6 |
| Accounts Payable, % | 22.78 | 29.33 | 47.83 | 60.22 | 533.58 | 52.03 | 52.03 | 52.03 | 52.03 | 52.03 |
| Capital Expenditure | -2.6 | -2.9 | -6.5 | -10.8 | -7.7 | -2.3 | -1.8 | -1.4 | -1.1 | -.8 |
| Capital Expenditure, % | -5.17 | -6.82 | -22.21 | -30.57 | -66.74 | -26.3 | -26.3 | -26.3 | -26.3 | -26.3 |
| Tax Rate, % | 0.80111 | 0.80111 | 0.80111 | 0.80111 | 0.80111 | 0.80111 | 0.80111 | 0.80111 | 0.80111 | 0.80111 |
| EBITAT | -47.6 | -108.1 | -179.8 | -248.7 | -436.4 | -8.7 | -6.7 | -5.1 | -3.9 | -3.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -44.2 | -100.9 | -164.3 | -254.1 | -390.9 | -64.7 | -7.3 | -5.6 | -4.3 | -3.3 |
| WACC, % | 10.96 | 10.96 | 10.96 | 10.96 | 10.96 | 10.96 | 10.96 | 10.96 | 10.96 | 10.96 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -73.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -3 | |||||||||
| Terminal Value | -38 | |||||||||
| Present Terminal Value | -22 | |||||||||
| Enterprise Value | -95 | |||||||||
| Net Debt | -608 | |||||||||
| Equity Value | 513 | |||||||||
| Diluted Shares Outstanding, MM | 113 | |||||||||
| Equity Value Per Share | 4.53 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financials for Revolution Medicines, Inc. (RVMD).
- Real-Time Data: Historical financial data and forward-looking projections (highlighted in the yellow cells).
- Assumption Flexibility: Modify assumptions such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Revolution Medicines, Inc. (RVMD).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for simplicity and user-friendliness, complete with detailed instructions.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Revolution Medicines, Inc. (RVMD).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to RVMD.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Revolution Medicines' projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Revolution Medicines, Inc. (RVMD).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel file for Revolution Medicines, Inc. (RVMD).
- Step 2: Review the pre-filled financial data and forecasts for Revolution Medicines, Inc. (RVMD).
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells) for Revolution Medicines, Inc. (RVMD).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions for Revolution Medicines, Inc. (RVMD).
- Step 5: Evaluate the outputs and utilize the results for your investment decisions regarding Revolution Medicines, Inc. (RVMD).
Why Choose the Revolution Medicines, Inc. (RVMD) Calculator?
- Accuracy: Utilizes real Revolution Medicines financial data for precise calculations.
- Flexibility: Allows users to easily experiment and adjust inputs as needed.
- Time-Saving: Eliminate the complexity of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with varying levels of financial modeling knowledge.
Who Should Use This Product?
- Investors: Evaluate Revolution Medicines, Inc. (RVMD) to inform stock trading decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and validate financial forecasts.
- Biotech Entrepreneurs: Understand the valuation strategies of established biotech firms like Revolution Medicines.
- Consultants: Provide comprehensive valuation analyses for clients in the biotech sector.
- Students and Educators: Utilize current market data to explore and teach valuation concepts.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Revolution Medicines, Inc. (RVMD).
- Real-World Data: Revolution Medicines' historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company's performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Revolution Medicines, Inc. (RVMD).
- Dashboard with Visual Outputs: Interactive charts and tables providing clear, actionable results for stakeholders.